Page 298 - Williams Hematology ( PDFDrive )

272 Part IV: Molecular and Cellular Hematology Chapter 18: Hematopoietic Stem Cells, Progenitors, and Cytokines 273

60. Scherr M, Battmer K, Blomer U, et al: Lentiviral gene transfer into peripheral blood-de- 91. Fang F, Orend G, Watanabe N, et al: Dependence of cyclin E-CDK2 kinase activity on
rived CD34+ NOD/SCID-repopulating cells. Blood 99:709, 2002. cell anchorage. Science 271:499, 1996.
61. Cashman J, Dykstra B, Clark-Lewis I, et al: Changes in the proliferative activity of 92. Pozzi A, Wary KK, Giancotti FG, et al: Integrin alpha1beta1 mediates a unique col-
human hematopoietic stem cells in NOD/SCID mice and enhancement of their trans- lagen-dependent proliferation pathway in vivo. J Cell Biol 142:587, 1998.
plantability after in vivo treatment with cell cycle inhibitors. J Exp Med 196:1141, 2002. 93. Tropel P, Roullot V, Vernet M, et al: A 2.7-kb portion of the 5′ flanking region of the
62. Guenechea G, Segovia JC, Albella B, et al: Delayed engraftment of nonobese diabetic/ murine glycoprotein alphaIIb gene is transcriptionally active in primitive hematopoi-
severe combined immunodeficient mice transplanted with ex vivo-expanded human etic progenitor cells. Blood 90:2995, 1997.
CD34(+) cord blood cells. Blood 93:1097, 1999. 94. Kovach NL, Lin N, Yednock T, et al: Stem cell factor modulates avidity of alpha 4 beta
63. Ueda T, Tsuji K, Yoshino H, et al: Expansion of human NOD/SCID-repopulating cells 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood 85:159,
by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J 1995.
Clin Invest 105:1013, 2000. 95. Zauli G, Bassini A, Vitale M, et al: Thrombopoietin enhances the alpha IIb beta
64. Zielske SP, Gerson SL: Cytokines, including stem cell factor alone, enhance lentiviral 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI
transduction in nondividing human LTCIC and NOD/SCID repopulating cells. Mol 3 kinase. Blood 89:883, 1997.
Ther 7:325, 2003. 96. Peled A, Kollet O, Ponomaryov T, et al: The chemokine SDF-1 activates the integrins
65. Glimm H, Oh IH, Eaves CJ: Human hematopoietic stem cells stimulated to proliferate LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: Role in transendothe-
in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter lial/stromal migration and engraftment of NOD/SCID mice. Blood 95:3289, 2000.
G(0). Blood 96:4185, 2000. 97. Papayannopoulou T: Mechanisms of stem-/progenitor-cell mobilization: The anti-
66. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of haemo- VLA-4 paradigm. Semin Hematol 37:11, 2000.
poietic stem cells in vitro. J Cell Physiol 91:335, 1977. 98. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug
67. Coulombel L, Eaves AC, Eaves CJ: Enzymatic treatment of long-term human marrow efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991.
cultures reveals the preferential location of primitive hemopoietic progenitors in the 99. Wolf NS, Kone A, Priestley GV, et al: In vivo and in vitro characterization of long-term
adherent layer. Blood 62:291, 1983. repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rho-
68. Sutherland HJ, Lansdorp PM, Henkelman DH, et al: Functional characterization of damine 123 FACS selection. Exp Hematol 21:614, 1993.
individual human hematopoietic stem cells cultured at limiting dilution on supportive 100. Ariki R, Morikawa S, Mabuchi Y, et al: Homeodomain transcription factor meis1 is a
marrow stromal layers. Proc Natl Acad Sci U S A 87:3584, 1990. critical regulator of adult bone marrow hematopoiesis. PLoS One 9:e87646, 2014.
69. Ploemacher RE, van der Sluijs JP, Voerman JS, et al: An in vitro limiting-dilution assay 101. Simsek, T, Kocabas, F, Zheng J, et al: The distinct metabolic profile of hematopoietic
of long-term repopulating hematopoietic stem cells in the mouse. Blood 74:2755, stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7, 380, 2010.
1989. 102. Klimmeck D, Hansson J, Raffel S, et al: Proteomic cornerstones of hematopoietic stem
70. Fackler MJ, Krause DS, Smith OM, et al: Full-length but not truncated CD34 inhibits cell differentiation: distinct signatures of multipotent progenitors and myeloid commit-
hematopoietic cell differentiation of M1 cells. Blood 85:3040, 1995. ted cells. Mol Cell Proteomics 11, 286, 2012.
71. Krause DS, Fackler MJ, Civin CI, et al: CD34: Structure, biology, and clinical utility. 102. Habibian HK, Peters SO, Hsieh CC, et al: The fluctuating phenotype of the lymphohe-
Blood 87:1, 1996. matopoietic stem cell with cell cycle transit. J Exp Med 188:393, 1998.
72. Verfaillie CM: Adhesion receptors as regulators of the hematopoietic process. Blood 103. Orschell-Traycoff CM, Hiatt K, Dagher RN, et al: Homing and engraftment potential
92:2609, 1998. of Sca-1(+)lin(–) cells fractionated on the basis of adhesion molecule expression and
73. Baum CM, Weissman IL, Tsukamoto AS, et al: Isolation of a candidate human hemato- position in cell cycle. Blood 96:1380, 2000.
poietic stem-cell population. Proc Natl Acad Sci U S A 89:2804, 1992. 104. Stier S, Cheng T, Forkert R, et al: Ex vivo targeting of p21Cip1/Waf1 permits relative
74. Barda-Saad M, Rozenszajn LA, Ashush H, et al: Adhesion molecules involved in the expansion of human hematopoietic stem cells. Blood 102:1260, 2003.
interactions between early T cells and mesenchymal bone marrow stromal cells. Exp 105. Lambert JF, Liu M, Colvin GA, et al: Marrow stem cells shift gene expression and
Hematol 27:834, 1999. engraftment phenotype with cell cycle transit. J Exp Med 197:1563, 2003.
75. Sanchez MJ, Holmes A, Miles C, et al: Characterization of the first definitive hemato- 106. Wilpshaar J, Falkenburg JH, Tong X, et al: Similar repopulating capacity of mitotically
poietic stem cells in the AGM and liver of the mouse embryo. Immunity 5:513, 1996. active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice. Blood
76. Broudy VC: Stem cell factor and hematopoiesis. Blood 90:1345, 1997. 96:2100, 2000.
77. Broudy VC, Lin NL, Kaushansky K: Thrombopoietin (c-mpl ligand) acts synergistically 107. Hu M, Krause D, Greaves M, et al: Multilineage gene expression precedes commitment
with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakary- in the hemopoietic system. Genes Dev 11:774, 1997.
ocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719, 1995. 108. Miyamoto T, Iwasaki H, Reizis B, et al: Myeloid or lymphoid promiscuity as a critical
78. Dean YD, McGreal EP, Akatsu H, et al: Molecular and cellular properties of the rat AA4 step in hematopoietic lineage commitment. Dev Cell 3:137, 2002.
antigen, a C-type lectin-like receptor with structural homology to thrombomodulin. J 109. Nutt SL, Heavey B, Rolink AG, et al: Commitment to the B-lymphoid lineage depends
Biol Chem 275:34382, 2000. on the transcription factor Pax5. Nature 401:556, 1999.
79. Uchida N, Weissman IL: Searching for hematopoietic stem cells: Evidence that Thy- 110. Phillips RL, Ernst RE, Brunk B, et al: The genetic program of hematopoietic stem cells.
1.110 Lin– Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Science 288:1635, 2000.
Exp Med 175:175, 1992. 111. Terskikh AV, Easterday MC, Li L, et al: From hematopoiesis to neuropoiesis: Evidence
80. Ito CY, Li CY, Bernstein A, et al: Hematopoietic stem cell and progenitor defects in of overlapping genetic programs. Proc Natl Acad Sci U S A 98:7934, 2001.
Sca-1/Ly-6A-null mice. Blood 101:517, 2003. 112. Lessard J, Sauvageau G: Bmi-1 determines the proliferative capacity of normal and leu-
81. Miraglia S, Godfrey W, Yin AH, et al: A novel five-transmembrane hematopoietic stem kaemic stem cells. Nature 423:255, 2003.
cell antigen: Isolation, characterization, and molecular cloning. Blood 90:5013, 1997. 113. Tadokoro Y, Ema H, Okano M, Li E, Nakauchi H: De novo DNA methyltransferase is
82. Fargeas CA, Florek M, Huttner WB, et al: Characterization of prominin-2, a new essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J Exp
member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem Med 204:715, 2007.
278:8586, 2003. 114. Starnes LM, Sorrentino A: Regulatory circuitries coordinated by transcription factors
83. Watt SM, Buhring HJ, Rappold I, et al: CD164, a novel sialomucin on CD34(+) and and microRNAs at the cornerstone of hematopoietic stem cell self-renewal and differ-
erythroid subsets, is located on human chromosome 6q21. Blood 92:849, 1998. entiation. Curr Stem Cell Res Ther 6:142, 2011.
84. Zannettino AC, Buhring HJ, Niutta S, et al: The sialomucin CD164 (MGC-24v) is an 115. Cillo C, Cantile M, Faiella A, et al: Homeobox genes in normal and malignant cells. J
adhesive glycoprotein expressed by human hematopoietic progenitors and bone mar- Cell Physiol 188:161, 2001.
row stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 116. Magli MC, Largman C, Lawrence HJ: Effects of HOX homeobox genes in blood cell
92:2613, 1998. differentiation. J Cell Physiol 173:168, 1997.
85. Kiel MJ, Yilmaz OH, Iwashita T, et al: SLAM family receptors distinguish hematopoietic 117. Sauvageau G, Thorsteinsdottir U, Eaves CJ, et al: Overexpression of HOXB4 in hemato-
stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109, poietic cells causes the selective expansion of more primitive populations in vitro and in
2005. vivo. Genes Dev 9:1753, 1995..
86. Zeigler FC, de Sauvage F, Widmer HR, et al: In vitro megakaryocytopoietic and throm- 118. Lawrence HJ, Helgason CD, Sauvageau G, et al: Mice bearing a targeted interruption of
bopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hemato-
Blood 84:4045, 1994. poiesis. Blood 89:1922, 1997.
87. Solar GP, Kerr WG, Zeigler FC, et al: Role of c-mpl in early hematopoiesis. Blood 92:4, 119. Yagi H, Deguchi K, Aono A, et al: Growth disturbance in fetal liver hematopoiesis of
1998. Mll-mutant mice. Blood 92:108, 1998.
88. Kent DG, Copley MR, Benz C, et al: Prospective isolation and molecular characteriza- 120. DiMartino JF, Selleri L, Traver D, et al: The Hox cofactor and proto-oncogene Pbx1 is
tion of hematopoietic stem cells with durable self-renewal potential. Blood 113:6342, required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98:618,
2009. 2001.
89. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 121. Calvo KR, Knoepfler PS, Sykes DB, et al: Meis1a suppresses differentiation by G-CSF
1992. and promotes proliferation by SCF: Potential mechanisms of cooperativity with Hoxa9
90. Fukai F, Mashimo M, Akiyama K, et al: Modulation of apoptotic cell death by extra- in myeloid leukemia. Proc Natl Acad Sci U S A 98:13120, 2001.
cellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp Cell Res 122. Georgopoulos K: Transcription factors required for lymphoid lineage commitment.
242:92, 1998. Curr Opin Immunol 9:222, 1997.

Kaushansky_chapter 18_p0257-0278.indd 273 9/19/15 12:06 AM